ARTICLE | Company News
Icagen, Bristol-Myers deal
October 29, 2001 8:00 AM UTC
The companies renewed their 1997 agreement to discover and develop small molecule compounds targeting ion channels involved in atrial fibrillation, or irregular heartbeat (see BioCentury, Oct. 6, 1997...